Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers

Documenti analoghi

• Real‐world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia
  di: Alexandra E. Rojek, et al.
  Pubblicazione: (2024)
• Real‐World Outcomes of Relapsed/Refractory Core‐Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study
  di: Alexandra E. Rojek, et al.
  Pubblicazione: (2025)
• Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
  di: Peiqi Liang, et al.
  Pubblicazione: (2024)
• Code Analyzer: A Privacy-First, Client-Side Static Analysis Framework
  di: Mohammed Talha, et al.
  Pubblicazione: (2026)
• Arguing The Unarguable
  di: Guru Dev Teeluckdharry
  Pubblicazione: (2026)